Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Magazine

Table: Nuking Cancer


Two new drugs use antibodies to deliver radiation directly to the tumor cell.

ZEVALIN

Combines antibody with yttrium-90 for treatment of non-Hodgkin's lymphoma

Maker: IDEC Pharmaceuticals

Status: Recommended by FDA advisory panel on Sept. 11

BEXXAR

Antibody combined with iodine-131, also for non-Hodgkin's

Maker: Corixa/GlaxoSmithKline

Status: Completed FDA application filing on Sept. 7


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus